BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 25492934)

  • 1. The effect of MPOWER on smoking prevalence.
    Dubray J; Schwartz R; Chaiton M; O'Connor S; Cohen JE
    Tob Control; 2015 Nov; 24(6):540-2. PubMed ID: 25492934
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Seven years of progress in tobacco control: an evaluation of the effect of nations meeting the highest level MPOWER measures between 2007 and 2014.
    Levy DT; Yuan Z; Luo Y; Mays D
    Tob Control; 2018 Jan; 27(1):50-57. PubMed ID: 27956650
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tobacco Control Progress in Low and Middle Income Countries in Comparison to High Income Countries.
    Anderson CL; Becher H; Winkler V
    Int J Environ Res Public Health; 2016 Oct; 13(10):. PubMed ID: 27783060
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of MPOWER scores on cigarette smoking prevalence and consumption.
    Ngo A; Cheng KW; Chaloupka FJ; Shang C
    Prev Med; 2017 Dec; 105S():S10-S14. PubMed ID: 28502576
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The status of tobacco control in the Eastern Mediterranean Region: progress in the implementation of the MPOWER measures.
    El-Awa F; Bettcher D; Al-Lawati JA; Alebshehy R; Gouda H; Fraser CP
    East Mediterr Health J; 2020 Jan; 26(1):102-109. PubMed ID: 32043552
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The potential impact of smoking control policies on future global smoking trends.
    Méndez D; Alshanqeety O; Warner KE
    Tob Control; 2013 Jan; 22(1):46-51. PubMed ID: 22535364
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Revisiting the association between worldwide implementation of the MPOWER package and smoking prevalence, 2008-2017.
    Husain MJ; Datta BK; Nargis N; Iglesias R; Perucic AM; Ahluwalia IB; Tripp A; Fatehin S; Husain MM; Kostova D; Richter P
    Tob Control; 2021 Nov; 30(6):630-637. PubMed ID: 32893187
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tracking MPOWER in 14 countries: results from the Global Adult Tobacco Survey, 2008-2010.
    Song Y; Zhao L; Palipudi KM; Asma S; Morton J; Talley B; Hsia J; Ramanandraibe N; Caixeta R; Fouad H; Khoury R; Sinha D; Rarick J; Bettcher D; Peruga A; Deland K; D'Espaignet ET;
    Glob Health Promot; 2016 Jun; 23(2 Suppl):24-37. PubMed ID: 24042973
    [TBL] [Abstract][Full Text] [Related]  

  • 9. WHO MPOWER tobacco control scores in the Eastern Mediterranean countries based on the 2011 report.
    Heydari G; Talischi F; Algouhmani H; Lando HA; Ahmady AE
    East Mediterr Health J; 2013 Apr; 19(4):314-9. PubMed ID: 23882955
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Global smoking-related deaths averted due to MPOWER policies implemented at the highest level between 2007 and 2020.
    Lyle G; Hendrie D
    Global Health; 2024 May; 20(1):40. PubMed ID: 38715053
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [MPOWER--strategy for fighting the global tobacco epidemic].
    Kaleta D; Kozieł A; Miśkiewicz P
    Med Pr; 2009; 60(2):145-9. PubMed ID: 19606747
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An overview of tobacco control and prevention policy status in Africa.
    Husain MJ; English LM; Ramanandraibe N
    Prev Med; 2016 Oct; 91S():S16-S22. PubMed ID: 26876626
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Implementation of MPOWER Package in the South-East Asia Region: Evidence from the WHO Report on the Global Tobacco Epidemic (2009-2021).
    Kaur J; Rinkoo AV; Gouda HN; Prasad V; Pendse RN
    Asian Pac J Cancer Prev; 2021 Nov; 22(S2):71-80. PubMed ID: 34780141
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of nations meeting the MPOWER targets between 2014 and 2016: an update.
    Levy DT; Li Y; Yuan Z
    Tob Control; 2020 Mar; 29(2):231-233. PubMed ID: 31053650
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of tobacco control policies on smoking prevalence and smoking-attributable deaths. Findings from the Netherlands SimSmoke Tobacco Control Policy Simulation Model.
    Nagelhout GE; Levy DT; Blackman K; Currie L; Clancy L; Willemsen MC
    Addiction; 2012 Feb; 107(2):407-16. PubMed ID: 21906197
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association between Tobacco Industry Interference Index (TIII) and MPOWER measures and adult daily smoking prevalence rate in 30 countries.
    Lee Y; Kim S; Kim MK; Kawachi I; Oh J
    Global Health; 2024 Jan; 20(1):6. PubMed ID: 38172937
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of public policies in reducing smoking prevalence: results from the Michigan SimSmoke tobacco policy simulation model.
    Levy DT; Huang AT; Havumaki JS; Meza R
    Cancer Causes Control; 2016 May; 27(5):615-25. PubMed ID: 26983616
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Investing in Tobacco Control: Twelve Years of MPOWER Measures and Progress in the Western Pacific Region.
    De Pinho Campos K; Kashiwabara M; Teakle A; De Guzman R; Lannan K; Mercado S
    Asian Pac J Cancer Prev; 2020 Jul; 21(S1):9-16. PubMed ID: 32649165
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Key Policy Makers' Awareness of Tobacco Taxation Effectiveness through a Sensitization Program.
    Heydari G; Ebn Ahmady A; Lando HA; Chamyani F; Masjedi M; Shadmehr MB; Fadaizadeh L
    Arch Iran Med; 2015 Dec; 18(12):849-51. PubMed ID: 26621018
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Germany SimSmoke: the effect of tobacco control policies on future smoking prevalence and smoking-attributable deaths in Germany.
    Levy DT; Blackman K; Currie LM; Mons U
    Nicotine Tob Res; 2013 Feb; 15(2):465-73. PubMed ID: 22855886
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.